Premarin vaginal cream 0.625 mg/g

 
Premarin vaginal cream 0.625 mg/g Image

Images for reference only. Packaging will vary.


Ask A Pharmacist

Please feel free to ask our pharmacists any questions about Premarin vaginal cream.

Click Here To Ask A Question

Best Value On Brand Premarin vaginal cream 0.625 mg/g
Price: $0.99 per .g!
In Stock
Premarin vaginal cream 0.625 mg/g Prescription Required
42.500 g for $42.14 ($0.99 per .g)
Premarin vaginal cream from online pharmacy: United Kingdom
Guaranteed US Delivery
Compare at $3.55 per unit for the US brand. You Save 72%

Order Premarin vaginal cream 0.625 mg/g today and have it delivered quickly and discreetly to your home. For many medication products on our website, a prescription is often required. In other cases, no prescription is required for OTC (over the counter) drugs. If you desire to save on drugs, one alternative to your local store is to buy from an online pharmacy like The Drug Company. The Drug Company offers medications from a wide selection of licensed pharmacies, including a Canadian pharmacy. Many people trust prescription medications from Canada, as well as all of the pharmacies in our network.

About Premarin vaginal cream

What Premarin vaginal cream is used for

  • To treat vulvar and vaginal atrophy and kraurosis vulvae (itching, burning, dryness in or around the vagina, difficulty or burning on urination) associated with menopause.

  • To treat dyspareunia (pain during intercourse) associated with menopause.

Premarin Vaginal Cream should not be used by women with intact uteri unless it is prescribed in association with a progestin.

Premarin Vaginal Cream should be used only under the supervision of a doctor, with regular follow-up at least once a year to identify side effects associated with its use.

Your first follow-up visit should be within 3 to 6 months of starting treatment. Your visit may include a blood pressure check, a breast exam, a Pap smear and pelvic exam. You should have a mammogram before starting treatment and at regular intervals as recommended by your doctor. Your doctor may recommend some blood tests.

You should carefully discuss the risks and benefits of hormone replacement therapy (HRT) with your doctor. You should regularly talk with your doctor about whether you still need treatment with HRT.

What Premarin vaginal cream does

When using Premarin Vaginal Cream women are using a hormone, estrogen (i.e. conjugated estrogens CSD 0.625 mg/g). Premarin Vaginal Cream replaces estrogen specifically in and around the vagina which naturally decreases at menopause.

Estrogens are female hormones that are produced by a woman’s ovaries and are necessary for normal sexual development and the regulation of menstrual periods during the childbearing years.

When a woman is between the ages of 45 and 55, the ovaries normally stop making estrogens. This leads to a drop in body estrogen levels and marks the beginning of menopause (the end of monthly menstrual periods). A sudden drop in estrogen levels also occurs if both ovaries are removed during an operation before natural menopause takes place. This is referred to as surgical menopause.

When the estrogen levels begin dropping, some women develop very uncomfortable symptoms, such as feelings of warmth in the face, neck, and chest, or sudden intense episodes of heat and sweating (“hot flashes”) as well as vaginal symptoms. In some women the symptoms are mild; in others they can be severe. These symptoms may last a few months or longer.

When Premarin vaginal cream should not be used

Before using Premarin Vaginal Cream be sure to tell your doctor if you have any of the following medical problems, as Premarin Vaginal Cream should not be used under these conditions:

  • Known, suspected, or past history of breast cancer.

  • Known or suspected hormone-dependent cancer. Estrogens may increase the chances of getting certain types of cancers, including cancer of the breast or uterus. If you have or had cancer, talk with your healthcare provider about whether you should take Premarin Vaginal Cream.

  • Unexpected or unusual vaginal bleeding.

  • Have (or have had) blood clot disorders, including blood clots in the legs or lungs or thrombophlebitis (inflammation of the veins).

  • Serious liver disease.

  • Active or past history of heart disease, heart attacks or stroke.

  • If you are allergic to Premarin Vaginal Cream or any of its ingredients, or have had any unusual reactions to its ingredients (see What the medicinal ingredient is: and What the important nonmedicinal ingredients are:).

  • If you are pregnant or suspect you may be pregnant. Since pregnancy may be possible early in pre-menopause while you are still having spontaneous periods, the use of non-hormonal birth control should be discussed with your physician at this time. If you accidentally take estrogen during pregnancy, there is a small risk of your unborn child having birth defects.

  • If you have partially or completely lost vision due to blood vessel disease of the eye.

  • If you have overgrowth of the lining of the uterus.

What the medicinal ingredient is

Conjugated equine estrogens.

What the important nonmedicinal ingredients for Premarin vaginal cream are

The cream contains the following inactive ingredients: cetyl alcohol, cetyl esters wax, glycerin, glyceryl monostearate, methyl stearate, mineral oil, phenylethyl alcohol, propyl glycol monostearate, sodium lauryl sulfate, water purified, white wax.

What dosage forms Premarin vaginal cream comes in

Premarin Vaginal Cream is available in tubes of 14 g, each gram containing 0.625 mg of conjugated estrogens CSD. Each tube is accompanied with a calibrated plastic applicator.

You should follow the dosage regimen prescribed by your healthcare provider.

Instructions for Use of Applicator:

  1. Remove cap.

  2. Screw nozzle end of applicator onto the tube.

  3. Gently squeeze tube to force sufficient cream into the barrel to provide the prescribed dose.

  4. Unscrew applicator from tube.

  5. Place the applicator into the vaginal opening.

  6. To release medication, press plunger downward.

TO CLEANSE: Pull plunger out from barrel. Wash with mild soap and warm water.

DO NOT BOIL.


Warnings and Precautions

Serious Warnings and Precautions

The Women’s Health Initiative (WHI) is a large clinical study that assessed the benefits and risks of oral combined estrogen plus progestin therapy and oral estrogen-alone therapy compared with placebo (a pill with no active ingredients) in postmenopausal women.

The WHI trial indicated an increased risk of myocardial infarction (heart attack), stroke, breast cancer, pulmonary emboli (blood clots in the lungs) and deep vein thrombosis (blood clots in the large veins) in postmenopausal women taking oral combined estrogen plus progestin.

The WHI trial indicated an increased risk of stroke and deep vein thrombosis in postmenopausal women with prior hysterectomy (surgical removal of the uterus) taking oral estrogen-alone.

Therefore, you should highly consider the following:

  • There is an increased risk of developing invasive breast cancer, heart attack, stroke and blood clots in both lungs and large veins with the use of estrogen plus progestin therapy.

  • There is an increased risk of stroke and blood clots in the large veins with the use of estrogen-alone therapy.

  • Estrogens with or without progestins should not be used for the prevention of heart disease or stroke.

  • Estrogens with or without progestins should be used at the lowest effective dose and for the shortest period of time possible. Regular medical follow-up is advised.

Breast Cancer

The results of the WHI trial indicated an increased risk of breast cancer in postmenopausal women taking combined estrogen plus progestin compared to women taking placebo.

The results of the WHI trial indicated no difference in the risk of breast cancer in postmenopausal women with prior hysterectomy taking estrogen-alone compared to women taking placebo.

Estrogens should not be taken by women who have a personal history of breast cancer.

In addition, women with a family history of breast cancer or women with a history of breast lumps, breast biopsies or abnormal mammograms (breast x-rays) should consult with their doctor before starting HRT.

Women should have a mammogram before starting HRT and at regular intervals during treatment as recommended by their doctor.

Regular breast examinations by a doctor and regular breast self-examination are recommended for all women. You should review technique for breast self-examination with your doctor.

Overgrowth of the Lining of the Uterus and Cancer of the Uterus

The use of estrogen-alone therapy by postmenopausal women who still have a uterus increases the risk of developing endometrial hyperplasia (overgrowth of the lining of the uterus), which increases the risk of endometrial cancer (cancer of the lining of the uterus).

If you still have your uterus, you should take a progestin medication (another hormone drug) regularly for a certain number of days of each month to reduce the risk of endometrial hyperplasia.

You should discuss progestin therapy and risk factors for endometrial hyperplasia and endometrial carcinoma with you doctor. You should also report any unexpected or unusual vaginal bleeding to your doctor.

If you have had your uterus removed, you are not at risk of developing endometrial hyperplasia or endometrial carcinoma. Progestin therapy is therefore not generally required in women who have had a hysterectomy.

Heart Disease and Stroke

The results of the WHI trial indicated an increased risk of stroke and coronary heart disease in postmenopausal women taking combined estrogen plus progestin compared to women taking placebo.

The results of the WHI trial indicated an increased risk of stroke, but no difference in the risk of coronary heart disease in postmenopausal women with prior hysterectomy taking estrogen-alone compared to women taking placebo.

Abnormal Blood Clotting

The results of the WHI trial indicated an increased risk of blood clots in the lungs and large veins in postmenopausal women taking combined estrogen plus progestin compared to women taking placebo.

The results of the WHI trial indicated an increased risk of blood clots in the large veins, but no difference in the risk of blood clots in the lungs in postmenopausal women with prior hysterectomy taking estrogen-alone compared to women taking placebo.

The risk of blood clots also increases with age, if you or a family member has had blood clots, if you smoke or if you are severely overweight. The risk of blood clots is also temporarily increased if you are immobilized for long periods of time and following major surgery. You should discuss risk factors for blood clots with your doctor since blood clots can be life-threatening or cause serious disability.

Gallbladder Disease

The use of estrogens by postmenopausal women has been associated with an increased risk of gallbladder disease requiring surgery.

Dementia

The Women's Health Initiative Memory Study (WHIMS) was a substudy of the WHI trial and indicated an increased risk of dementia (loss of memory and intellectual function) in postmenopausal women age 65 and over taking oral combined estrogen plus progestin compared to women taking placebo.

The WHIMS indicated no difference in the risk of dementia in postmenopausal women age 65 and over with prior hysterectomy taking oral estrogen-alone compared to women taking placebo.

BEFORE you use Premarin Vaginal Cream talk to your doctor or pharmacist if you:

  • have a history of allergy or intolerance to any medications or other substances

  • have a personal history of breast disease (including breast lumps) and/or breast biopsies, or a family history of breast cancer

  • have experienced any unusual or undiagnosed vaginal bleeding

  • have a history of uterine fibroids or endometriosis

  • have a history of liver disease, jaundice (yellowing of the eyes and/or skin) or itching related to estrogen use or during pregnancy

  • have a history of migraine headache

  • have a history of high blood pressure

  • have a personal or family history of blood clots, or a personal history of heart disease or stroke

  • have a history of kidney disease, asthma or epilepsy (seizures)

  • have a history of bone disease (this includes certain metabolic conditions or cancers that can affect blood levels of calcium and phosphorus)

  • have been diagnosed with diabetes

  • have been diagnosed with porphyria (a disease of blood pigment)

  • have a history of high cholesterol or high triglycerides

  • are pregnant or may be pregnant

  • have had a hysterectomy (surgical removal of the uterus)

  • smoke

Other existing conditions you should discuss with your health professional include lupus, very low calcium levels, thyroid problems, fluid retention, gallbladder disease, depression, and breast-feeding. If you have upcoming surgery or prolonged bedrest, you should also discuss these.


Interactions with Premarin vaginal cream

Tell your doctor or pharmacist if you are taking any other medications, including prescription medications, over-the-counter medications, vitamins or herbal products (such as St. John’s wort). Some medications (such as medications for high blood pressure, diabetes, blood clots, sleeping, anxiety, seizures, pain-relief and tuberculosis) may affect how Premarin Vaginal Cream works. Premarin Vaginal Cream may also affect how other medicines work.


Proper Use of Premarin vaginal cream

Usual dose

You should follow the dosage regimen prescribed by your healthcare provider.

Estrogens should be used at the lowest dose possible for your treatment only as long as needed. You and your healthcare provider should talk regularly (for example every 3 to 6 months) about the dose you are taking and whether you still need treatment with Premarin Vaginal Cream.

Do not give Premarin Vaginal Cream to other people, even if they have the same symptoms you have. It may harm them.

Overdose

Contact your physician or local Poison Control Center in case of accidental ingestion of high doses of Premarin Vaginal Cream.

Overdosage with estrogens may cause nausea and vomiting, breast discomfort, fluid retention, bloating or vaginal bleeding may occur in women. There is no specific antidote and further treatment if necessary should be symptomatic.

Overdosage may result in a period of amenorrhea (lack of menses) of a variable length and may be followed by irregular menses for several cycles. No cases of overdosage in male patients have been reported.

Missed dose

If you miss a dose, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your normal schedule. Do not use 2 doses at the same time.


Technical Information